RMG Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$285K Hold
1,001
– – 0.03% 58
2026
Q2
$249K Buy
1,001
+83
+9% +$17.9K 0.03% 65
2026
Q1
$186K Buy
918
+496
+118% +$110K 0.02% 75
2025
Q4
$91.8K Buy
422
+73
+21% +$16.6K 0.01% 109
2025
Q3
$80.7K Sell
349
-56
-14% -$11.4K 0.01% 106
2025
Q2
$76.9K Buy
+405
New +$75.3K 0.01% 102

Other funds holding ABBV

RMG Wealth Management's ABBV Position: Q3 2026 in Review

RMG Wealth Management held its AbbVie (ABBV) position steady in Q3 2026 at 1,001 shares worth $285K. The position accounts for 0.03% of the portfolio, ranked #58.

RMG Wealth Management first reported a position in ABBV in Q2 2025 and has held it in 6 quarters since. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • RMG Wealth Management held 1,001 shares of AbbVie worth $285K as of Q3 2026.
  • RMG Wealth Management left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.03% of RMG Wealth Management's portfolio in Q3 2026, its #58 holding.
  • RMG Wealth Management first reported a position in AbbVie in Q2 2025 and has held it in 6 quarters since.
  • 3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on RMG Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.